PerkinElmer Announces Successful Completion of Cash Tender Offer for ViaCell

PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced the successful completion of its tender offer to acquire all outstanding shares of common stock of ViaCell, Inc. (Nasdaq: VIAC), at a price of $7.25 per share, in cash.

Source: PerkinElmer, Inc.